Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hildesheim

Showing results (191-200 of 533) with videos related to

Pageof 54
Sort By:
The Journal of Infectious Diseases|January 13, 2009
Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycleMahboobeh Safaeian, Roni T Falk, Ana Cecilia Rodriguez, et al.
Journal of the National Cancer Institute|December 7, 2014
Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testingCarolina Porras, Allan Hildesheim, Paula González, et al.
Vaccine|March 24, 2026
Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring studyRomain Fantin, Sanchita Das, Viviana Loria, et al.
Vaccine|January 19, 2011
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionTroy J Kemp, Allan Hildesheim, Mahboobeh Safaeian, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
The epidemiology of oral HPV infection among a multinational sample of healthy menAimee R Kreimer, Alessandro Villa, Alan G Nyitray, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2005
Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in TaiwanXiaohong Rose Yang, Scott Diehl, Ruth Pfeiffer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancerC Bodelon, M Y Polley, T J Kemp, et al.
Journal of the National Cancer Institute|January 20, 2005
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman, Michelle J Khan, Diane Solomon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout miceGisbert Weckbecker, Christian Bruns, Klaus-Dieter Fischer, et al.
Vaccine|November 6, 2012
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Troy J Kemp, Mahboobeh Safaeian, Allan Hildesheim, et al.
Pageof 54

Showing results (191-200 of 533) with videos related to

Sort By:
Pageof 54
The Journal of Infectious Diseases|January 13, 2009
Factors associated with fluctuations in IgA and IgG levels at the cervix during the menstrual cycleMahboobeh Safaeian, Roni T Falk, Ana Cecilia Rodriguez, et al.
Journal of the National Cancer Institute|December 7, 2014
Performance of self-collected cervical samples in screening for future precancer using human papillomavirus DNA testingCarolina Porras, Allan Hildesheim, Paula González, et al.
Vaccine|March 24, 2026
Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring studyRomain Fantin, Sanchita Das, Viviana Loria, et al.
Vaccine|January 19, 2011
HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protectionTroy J Kemp, Allan Hildesheim, Mahboobeh Safaeian, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 15, 2010
The epidemiology of oral HPV infection among a multinational sample of healthy menAimee R Kreimer, Alessandro Villa, Alan G Nyitray, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2005
Evaluation of risk factors for nasopharyngeal carcinoma in high-risk nasopharyngeal carcinoma families in TaiwanXiaohong Rose Yang, Scott Diehl, Ruth Pfeiffer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 18, 2013
Circulating levels of immune and inflammatory markers and long versus short survival in early-stage lung cancerC Bodelon, M Y Polley, T J Kemp, et al.
Journal of the National Cancer Institute|January 20, 2005
A study of the impact of adding HPV types to cervical cancer screening and triage testsMark Schiffman, Michelle J Khan, Diane Solomon, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|March 1, 2007
Strongly reduced alloreactivity and long-term survival times of cardiac allografts in Vav1- and Vav1/Vav2-knockout miceGisbert Weckbecker, Christian Bruns, Klaus-Dieter Fischer, et al.
Vaccine|November 6, 2012
Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix(®)Troy J Kemp, Mahboobeh Safaeian, Allan Hildesheim, et al.
Pageof 54